U.S. Exosomes Market Is Set For Lucrative Growth
U.S. Exosomes Market Summary The U.S. exosomes market size was valued at USD 73.58 million in 2023 and is projected to grow at a CAGR of 34.20% from 2024 to 2030. This strong growth trajectory is attributed to the expanding applications of exosomes across healthcare and research domains. Continuous technological advancements in exosome isolation and analytical techniques have significantly improved precision and reliability, further accelerating adoption. Additionally, the rising prevalence of cancer is fueling the need for exosome-based diagnostics and therapeutics. Government and non-government funding initiatives aimed at advancing exosome research are expected to generate new opportunities, supporting long-term market expansion. The U.S. accounted for 52.0% of the global exosomes market share, underlining its dominant position. Increasing interest from the pharmaceutical sector in developing exosome-based therapies is driving substantial progress. Exosomes are no...